Introduction Alpha‐fetoprotein (AFP) has a valuable role in postoperative surveillance for
hepatocellular carcinoma (HCC) recurrence. The utility of pretreatment or baseline AFP …

The prognostic impact of serum α-fetoprotein (AFP) level in patients with hepatocellular
carcinoma (HCC) is controversial. This study aimed to investigate the predictive ability of …

Background and Aims The prognostic ability of α-fetoprotein (AFP) for patients with
hepatocellular carcinoma (HCC) was examined by using different cutoff values. The optimal …

AIM: To identify the clinical outcomes of hepatocellular carcinoma (HCC) patients with
inconsistent α-fetoprotein (AFP) levels which were initially high and then low at recurrence …

Introduction Although preoperative α-fetoprotein (AFP) has been recognized as an important
tumor marker among patients with hepatocellular carcinoma (HCC), the predictive value of …

Background Serum alpha-fetoprotein (AFP) is frequently used to predict posthepatectomy
outcomes in patients with hepatocellular carcinoma (HCC), but its predictive value is still not …

Background The clinical value of alpha-fetoprotein (AFP) in patients with AFP-negative (< 20
ng/ml) hepatocellular carcinoma (HCC) who underwent curative resection remained …

Background Serum α‐fetoprotein (AFP) is the most important tumor marker for
hepatocellular carcinoma (HCC). The reported predictive accuracy of AFP for HCC widely …

Background The value of alpha-fetoprotein (AFP) as a prognostic indicator in patients with
hepatocellular carcinoma (HCC) has been proposed in recent studies, but the evidence so …

UICC staging) and tumor size. Although this study is retrospective, it is of interest both by the
issue raised which is still contradictory and by the large size of the cohort studied by the …